Aerobic and combined exercise sessions reduce glucose variability in type 2 diabetes: crossover randomized trial

PLoS One. 2013;8(3):e57733. doi: 10.1371/journal.pone.0057733. Epub 2013 Mar 11.

Abstract

Purpose: To evaluate the effects of aerobic (AER) or aerobic plus resistance exercise (COMB) sessions on glucose levels and glucose variability in patients with type 2 diabetes. Additionally, we assessed conventional and non-conventional methods to analyze glucose variability derived from multiple measurements performed with continuous glucose monitoring system (CGMS).

Methods: Fourteen patients with type 2 diabetes (56±2 years) wore a CGMS during 3 days. Participants randomly performed AER and COMB sessions, both in the morning (24 h after CGMS placement), and at least 7 days apart. Glucose variability was evaluated by glucose standard deviation, glucose variance, mean amplitude of glycemic excursions (MAGE), and glucose coefficient of variation (conventional methods) as well as by spectral and symbolic analysis (non-conventional methods).

Results: Baseline fasting glycemia was 139±05 mg/dL and HbA1c 7.9±0.7%. Glucose levels decreased immediately after AER and COMB protocols by ∼16%, which was sustained for approximately 3 hours. Comparing the two exercise modalities, responses over a 24-h period after the sessions were similar for glucose levels, glucose variance and glucose coefficient of variation. In the symbolic analysis, increases in 0 V pattern (COMB, 67.0±7.1 vs. 76.0±6.3, P = 0.003) and decreases in 1 V pattern (COMB, 29.1±5.3 vs. 21.5±5.1, P = 0.004) were observed only after the COMB session.

Conclusions: Both AER and COMB exercise modalities reduce glucose levels similarly for a short period of time. The use of non-conventional analysis indicates reduction of glucose variability after a single session of combined exercises.

Trial registration: Aerobic training, aerobic-resistance training and glucose profile (CGMS) in type 2 diabetes (CGMS exercise). ClinicalTrials.gov ID: NCT00887094.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose*
  • Cross-Over Studies
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / therapy
  • Exercise Therapy
  • Exercise*
  • Female
  • Glucose / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Reproducibility of Results
  • Risk Factors

Substances

  • Blood Glucose
  • Glucose

Associated data

  • ClinicalTrials.gov/NCT00887094

Grants and funding

This study was partially supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico, grant 131847/2009-0; Fundação de Apoio à Pesquisa do Rio Grande do Sul, grant 05/1936-6; Fundo de Apoio à Pesquisa do Hospital de Clínicas de Porto Alegre, grant 08-180; and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, PNPD 2546/2009. The sponsors of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.